BWAY News & Events

BrainsWay announced it has entered into a strategic equity financing agreement with APS Innovations, the parent company of Advanced Psychiatric Management, a management services organization servicing multiple mental health clinics in the greater Chicago area. Under the terms of the agreement, BrainsWay will invest $1.5M initially, with potential for an additional $1.5M via milestone-based investments, for a minority position in Hopemark in the form of a preferred, annually compounding security. The agreement also provides for a redemption mechanism relating to the shares.

Reports Q1 revenue $15.53M, consensus $14.62M. "We are off to an excellent start in 2026, delivering 35% revenue growth in the first quarter while generating $2.8 million of Adjusted EBITDA," said Hadar Levy, CEO of BrainsWay. "Across the board, we are seeing meaningful progress in expanding awareness and access to Deep TMS, driven by broader reimbursement, increasing provider adoption, and continued engagement with leading mental health networks. These efforts are translating into growing demand, increased utilization, and strong momentum across our business."

Backs FY26 adjusted EBITDA view $12M-$14M. "We are off to an excellent start in 2026, delivering 35% revenue growth in the first quarter while generating $2.8 million of Adjusted EBITDA," said Hadar Levy, CEO of BrainsWay. "Across the board, we are seeing meaningful progress in expanding awareness and access to Deep TMS, driven by broader reimbursement, increasing provider adoption, and continued engagement with leading mental health networks. These efforts are translating into growing demand, increased utilization, and strong momentum across our business."